MedNation Yönetim

Mr. Dirk Isenberg serves as Member of Management Board of MedNation AG (formerly known as Eifelhöhen-Klinik AG) from October 2021 and has been its Chairman of Management Board and had served as its Chairma...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Klaus Dirks	Independent Chairman of the Supervisory Board	24.1yrs	Veri yok	Veri yok
Gabriele Buchholz	Independent Deputy Chair of Supervisory Board	3.3yrs	Veri yok	Veri yok
Robert Fortmeier	Member of Supervisory Board	3.3yrs	Veri yok	Veri yok

3.3yrs

Ortalama Görev Süresi

59yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: EIF's board of directors are considered experienced (3.3 years average tenure).

MedNation Yönetim

Yönetim kriter kontrolleri 1/4

Anahtar bilgiler

Son yönetim güncellemeleri

MedNation AG, Annual General Meeting, Jul 16, 2024

Recent updates

MedNation's (FRA:EIF) Earnings Are Weaker Than They Seem

First half 2024 earnings released: EPS: €0.099 (vs €0.17 loss in 1H 2023)

Market Might Still Lack Some Conviction On MedNation AG (FRA:EIF) Even After 25% Share Price Boost

Market Might Still Lack Some Conviction On MedNation AG (FRA:EIF) Even After 25% Share Price Boost

MedNation AG, Annual General Meeting, Jul 16, 2024

MedNation AG to Report Fiscal Year 2023 Results on Apr 30, 2024

New minor risk - Financial data availability

The Return Trends At MedNation (FRA:EIF) Look Promising

Investors Still Aren't Entirely Convinced By MedNation AG's (FRA:EIF) Revenues Despite 31% Price Jump

These 4 Measures Indicate That MedNation (FRA:EIF) Is Using Debt Extensively

MedNation (FRA:EIF) Is Looking To Continue Growing Its Returns On Capital

MedNation AG's (FRA:EIF) 32% Dip In Price Shows Sentiment Is Matching Earnings

New major risk - Share price stability

Returns On Capital Are Showing Encouraging Signs At MedNation (FRA:EIF)

Returns Are Gaining Momentum At Eifelhöhen-Klinik (FRA:EIF)

These 4 Measures Indicate That Eifelhöhen-Klinik (FRA:EIF) Is Using Debt Extensively

First half 2022 earnings released: €0.15 loss per share (vs €0.52 loss in 1H 2021)

Is Eifelhöhen-Klinik (FRA:EIF) Using Debt Sensibly?

Full year 2021 earnings released: €1.46 loss per share (vs €0.47 loss in FY 2020)

Eifelhöhen-Klinik AG to Report Fiscal Year 2021 Results on Apr 29, 2022

Is Eifelhöhen-Klinik (FRA:EIF) Using Debt In A Risky Way?

First half 2021 earnings released: €0.52 loss per share (vs €0.42 loss in 1H 2020)

Is Eifelhöhen-Klinik (FRA:EIF) Using Too Much Debt?

New 90-day low: €3.30

Will Eifelhöhen-Klinik's (FRA:EIF) Growth In ROCE Persist?

New 90-day high: €3.80

First half earnings released

Eifelhöhen-Klinik AG to Report Q2, 2020 Results on Sep 30, 2020

New 90-day high - €2.90

New 90-day high - €2.14

CEO

Görev süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş